Growth and long-term hormonal therapy

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 1, 2006, Pages 192-194

  Spiliotis, Bessie E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Estrogen; Growth; Hormonal therapy

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; SEX HORMONE;

BONE MASS; BONE MATURATION; CALCIFICATION; CELL GROWTH; CONFERENCE PAPER; DRUG MEGADOSE; GONADAL DYSGENESIS; GROWTH; HORMONAL THERAPY; HUMAN; HYPOGONADISM; LONG TERM EXPOSURE; LOW DRUG DOSE; MENSTRUATION; NERVE CELL PLASTICITY; OOCYTE; OVARY INSUFFICIENCY; PREGNANCY COMPLICATION; TURNER SYNDROME; UTERUS GROWTH; WELLBEING;

ADOLESCENT; BODY HEIGHT; BONE AND BONES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GROWTH; HUMANS; PUBERTY; TURNER SYNDROME;

EID: 33645416570     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Mann DR, Johnson AO, Gimpel T, Castracane VD. Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. J Clinc Endocr Metab 2003;88:3339-3345
2. Pralong FP, Voirol M, Giacomini M, Gaillard RC, Grouzmann E. Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors. Regul Pept 2000;95:47-52
3. Craig MC, Cutter WJ, Wickham H, van Amelsvoort TA, Rymer J, Whitehead M, Murphy DG. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women-a preliminary study. Psychoneuroendocrinology 2004;29:1309-1316
4. Aiello EJ, Tworger SS, Yasu Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTieman A. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2005;14:1411-4117
5. Spelsberg TC, Subramaniam M, Riggs BL, Khosia S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999;13:819-828
6. Josse RG. Prevention and management of Osteoporosis: Consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Can Med Assoc J 1996;155:929-934
7. Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cupples LA, Housman DE, Kiel DP. Estrogen receptor β polymorphisms are associated with bone mass in women and men: The Framingham Study. JBMR 2004;19:773-787
8. Zajickova K, Zofkova I, Hill M. Vitamin D receptor polymorphisms, bone ultrasound and mineral density in post-menopausal women. Aging Clin Exp Res 2005;17:121-124
9. Tinkler GP, Tobin JR, Voytko ML. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol 2004;469:507-521
10. Ross JL, Roeltgen D, Feullan P, Kushner H, Cutler GB, Jr. Effects of estrogens on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998;83:3198-3204
11. Ross JL, Roeltgen D, Feullan P, Kushner H, Cutler GB, Jr. Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 2000;54:164-170
12. Pinkerton JV, Henderson VW. Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med 2005;23:172-179
13. Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP. Optimizing estrogen replacement treatment in Turner Syndrome. Pediatrics 1998;102:486-488
14. Lieberman S. Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical? J Clin Endocrinol Metab 1996;81:850-853
15. Jensen E, Jacobsen H, Flescher J. Estrogen receptors in target tissues. In: Nakao T, Pincus G, Tait J eds. Steroid Dynamics. New York, NY, Academic Press 1966:133-157
16. Korenman S. Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 1969;13:163-177
17. Rosenfeld RL, Fang, VS. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teenagers. J Pediatr 1974;85:830-837
18. Ross J, Cassorla F, Skerda M, Valk L, Loriaux D, Cutler GJ. A preliminary study of effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1983;309:1104-1106
19. Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T Jr, Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab 2005;90:6424-6430
20. Schonberg MA, Davis RB, Wee CC. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Women's Health Issues 2005;15:187-195
21. Ho KK, O'Sullivan AJ, Wolthers T, Leung KC. Metabolic effects of oestrogens: impact of the route of administration. Ann Endocrinol (Paris) 2003;64:170-177
22. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 2003;41:1358-1363